Medxbio was formed by veterans of the industry with a vision to accommodate both the increasing regulatory requirements and the growing patients needs for quality yet affordable Biopharmaceuticals. In order to realize our vision we developed a unique products portfolio and complementary business approach.

Our products portfolio include first generation Biologicals and Biosimilars, generic and innovative patented Pharmaceuticals, and Medical Device Pharmaceuticals. Our products are manufactured exclusively for our group by in / out license agreements with European and Asian Pharmaceutical contract manufacturers, and commercialized from our Singapore head office.

With a strong presence in South East Asia and additional growing healthcare regions, Medxbio developed a global partnering approach, to accommodate the dynamics and requirements of the industry and effectively bring our products to market.

Medxbio is B2B driven and partnered with strategic alliances to support each country's unique commercial and regulatory requirements. With our partners, in-house team and strong marketing and sales capabilities, we introduced our portfolio to most countries around the world.

We currently have representation and offices in over 20 countries, and clients in many of SEA, Europe, LATAM, CIS and MENA countries.


Medxbio Pte. Ltd. is a Singapore based Biopharmaceutical company acting globally in the development and commercialization of Biologicals, Pharmaceuticals and Medical Devices